Secondary Hypertension Workup from a Nephrology Perspective
All patients with confirmed hypertension should be screened with a plasma aldosterone-to-renin ratio (ARR), as primary aldosteronism is the most common treatable renal cause of secondary hypertension, affecting 8-20% of resistant hypertension cases. 1, 2
When to Suspect Secondary Hypertension
Pursue aggressive workup in these clinical scenarios:
- Age of onset <30 years (or <40 years per ESC 2024 guidelines) 1, 3
- Resistant hypertension: BP >140/90 mmHg despite optimal doses of ≥3 antihypertensive drugs including a diuretic 1, 2
- Sudden onset or sudden deterioration of previously controlled hypertension 1, 3
- Hypertensive urgency or emergency 1, 3
- Target organ damage disproportionate to duration or severity of hypertension 1
Initial Laboratory Screening (Complete Before Imaging)
Basic panel for all suspected cases:
- Plasma aldosterone-to-renin ratio (ARR) - most critical test, now recommended for all confirmed hypertension 1, 2, 3
- Serum electrolytes (sodium, potassium) - hypokalemia strongly suggests primary aldosteronism 1, 3
- Serum creatinine and eGFR 1, 3
- Urinalysis with microscopy - look for blood, protein, and casts suggesting renal parenchymal disease 1, 3
- Urinary albumin-to-creatinine ratio 4, 1, 3
- Fasting blood glucose or HbA1c 1, 3
- Thyroid-stimulating hormone (TSH) 1, 3
- 12-lead ECG - assess for left ventricular hypertrophy 4, 3
Renal-Specific Clinical Clues
Renal Parenchymal Disease
Look for history of:
- Urinary tract infections, obstruction, hematuria 1
- Urinary frequency, nocturia 1
- Family history of polycystic kidney disease 1
Renovascular Disease (Renal Artery Stenosis)
Suspect when:
- Abrupt onset or worsening hypertension 1, 3
- Flash pulmonary edema 1, 3
- Serum creatinine increase ≥50% within one week of starting ACE inhibitor or ARB 3, 5
- Severe hypertension with unilateral smaller kidney or kidney size difference >1.5 cm 3, 5
- Abdominal systolic-diastolic bruit on examination 3
Targeted Renal Imaging
Only proceed after completing basic laboratory screening to avoid expensive unnecessary imaging 1, 3
For Renovascular Disease:
For Renal Parenchymal Disease:
- Renal ultrasound to assess kidney size, echogenicity, and structural abnormalities 4
Confirmatory Testing for Primary Aldosteronism
When ARR is positive (ratio >20 with elevated aldosterone and suppressed renin):
- Confirmatory tests: Oral sodium loading test with 24-hour urine aldosterone OR IV saline infusion test with plasma aldosterone at 4 hours 3
- Localization studies: Adrenal CT scan, followed by adrenal vein sampling if surgical intervention is considered 3
Critical Pitfalls to Avoid
- Do not perform expensive imaging (CT, MRI, angiography) before completing basic laboratory screening 1, 3
- Medications affect ARR interpretation: Mineralocorticoid receptor antagonists raise aldosterone; beta-blockers and direct renin inhibitors lower renin 1
- Delayed diagnosis leads to vascular remodeling, affecting renal function and resulting in residual hypertension even after treating the underlying cause 1, 2
- Never combine two RAS blockers (ACE inhibitor + ARB) due to increased risk of hyperkalemia, hypotension, and acute kidney injury 3
Management Based on Renal Causes
Primary Aldosteronism:
- Unilateral disease: Laparoscopic adrenalectomy 1, 3
- Bilateral disease: Spironolactone 50-100 mg daily 1, 3
Renovascular Disease:
- Atherosclerotic renal artery stenosis: Medical therapy preferred (statin, antiplatelet, ACE inhibitor/ARB, cardiovascular risk optimization) 3
- Fibromuscular dysplasia: Percutaneous transluminal renal angioplasty without stenting 1, 3
Renal Parenchymal Disease:
- Address underlying renal disease with specific treatments 1
- Monitor renal function carefully when using RAS blockers 1
Resistant Hypertension Protocol (After Excluding Secondary Causes)
- Optimize diuretic therapy: Use thiazide-like diuretics (not classic thiazides); consider loop diuretics for eGFR <30 ml/min/1.73m² 1
- Add spironolactone as fourth-line agent if K+ <4.5 mmol/L and eGFR >45 ml/min/1.73m² 1, 3
- Consider renal denervation for resistant hypertension uncontrolled despite three-drug combination 1
Recognize that 5-10% of all hypertensive patients have secondary causes, increasing to 10-20% in resistant cases - maintain a high index of suspicion from a nephrology perspective. 3, 5